Evidence map›Paper›PMID 32435418›Full record

ArticleACS medicinal chemistry letters2020

Phenolic Compounds from

Vladimir Heger, Barbora Benesova, Jana Viskupicova, Magdalena Majekova, Zoofishan Zoofishan, Attila Hunyadi, Lubica Horakova

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS medicinal chemistry letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Vladimir HegerInstitute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine SAS, Dubravska cesta 9, 841 01 Bratislava, Slovakia.
Barbora BenesovaInstitute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine SAS, Dubravska cesta 9, 841 01 Bratislava, Slovakia.
Jana ViskupicovaInstitute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine SAS, Dubravska cesta 9, 841 01 Bratislava, Slovakia.
Magdalena MajekovaInstitute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine SAS, Dubravska cesta 9, 841 01 Bratislava, Slovakia.
Zoofishan ZoofishanInstitute of Pharmacognosy, Interdisciplinary Excellence Centre, University of Szeged, Eötvös u. 6, 6720 Szeged, Hungary.
Attila HunyadiInstitute of Pharmacognosy, Interdisciplinary Excellence Centre, University of Szeged, Eötvös u. 6, 6720 Szeged, Hungary.
Lubica HorakovaInstitute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine SAS, Dubravska cesta 9, 841 01 Bratislava, Slovakia.
Centre of Experimental Medicine of the Slovak Academy of Sciences · SKUniversity of Szeged · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ability of phenolic compounds from

Identifiers

PMID32435418
PMCPMC7236539
OpenAlexW3013364058

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.